TABLE 418-1 -NAMES AND USUAL ADULT ORAL DOSES OF ANTI-HIV DRUGS
| DRUG | DOSAGE |
| Nucleoside Reverse Transcriptase Inhibitors | |
| Zidovudine (AZT) | 200 mg three times daily or 300 mg twice daily * |
| Didanosine (ddI) | >60 kg: 200 mg twice daily (tablets) between meals < 60 kg: 125 mg twice daily (tablets) between meals |
| Zalcitabine (ddC) | 0.75 mg three times daily |
| Stavudine (d4T) | >60 kg: 40 mg twice daily <60 mg: 30 mg twice daily |
| Lamivudine (3TC) | >50 kg: 150 mg twice daily * <50 kg: 2 mg/kg twice daily |
| Abacavir | 300 mg twice daily |
| Non-Nucleoside Reverse Transcriptase Inhibitors | |
| Nevirapine | 200 mg/d for 14 days, then 200 mg twice daily |
| Delavirdine | 400 mg three times daily (in water as slurry) |
| Efavirenz | 600 mg once daily at nighttime |
| Protease Inhibitors | |
| Indinavir | 800 mg q8h between meals or with low-fat meal |
| Ritonavir | 600 mg q12h with food if possible |
| Saquinavir | |
| Hard-gel capsule | 600 mg three times daily with large meal |
| Soft-gel capsule | 1200 mg three times daily with large meal |
| Nelfinavir | 750 mg three times daily with food or light snack |
* Zudovudine is also available in a combined capsule with lamivudine.
For the buffered powder formulation of didanosine, the doses are 250 mg twice daily for patients >60 kg and 167 mg twice daily for patients <60 kg.